We observed a trend toward reduced SVR with genotype 3a and to a lesser degree genotype 1a, but these did not reach statistical significance, as was the case in the US study that found SVR rates of 90.7% (429/473) for genotype 1 and 91.3% (42/46) for genotype 3 [ 28 ].
← all excerpts
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia.
1
—
—